Bictegravir (INN; BIC, formerly known as GS-9883) is a second-generation integrase inhibitor (INSTI) class that was structurally derived from an earlier...
13 KB (839 words) - 04:02, 28 February 2024
Bictegravir/emtricitabine/tenofovir alafenamide, sold under the brand name Biktarvy, is a fixed-dose combination antiretroviral medication for the treatment...
14 KB (1,200 words) - 03:35, 24 July 2024
the US in 2013, and in the EU in January 2014. The combination drug bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy), produced by Gilead Sciences...
6 KB (622 words) - 17:42, 23 December 2023
snatching endonuclease inhibitor 2018 Biktarvy (Bictegravir/emtricitabine/tenofovir alafenamide) HIV Bictegravir: INSTI Emtricitabine: NRTI Tenofovir alafenamide:...
13 KB (513 words) - 14:31, 4 May 2024
approved in the United States for HIV-1 pre-exposure prophylaxis (PrEP). Bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy) — approved in the United...
29 KB (1,823 words) - 05:48, 26 July 2024
Integrase inhibitors (Integrase strand transfer inhibitors (INSTI)) Bictegravir (BIC) Cabotegravir (CAB) Dolutegravir (DTG)# Elvitegravir (EVG) Raltegravir...
15 KB (1,230 words) - 02:38, 16 July 2024
clinically approved integrase inhibitors are elvitegravir, dolutegravir, bictegravir, and cabotegravir. Protease inhibitors block the viral protease enzyme...
133 KB (16,990 words) - 13:40, 24 August 2024
2024. "The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir". The Medicines Patent Pool. 4 October 2017. Prize Committee Virchow...
16 KB (1,362 words) - 05:51, 8 August 2024
Integrase inhibitors (Integrase strand transfer inhibitors (INSTI)) Bictegravir (BIC) Cabotegravir (CAB) Dolutegravir (DTG)# Elvitegravir (EVG) Raltegravir...
28 KB (2,975 words) - 02:18, 11 August 2024
alafenamide and rilpivirine J05AR20 Emtricitabine, tenofovir alafenamide and bictegravir J05AR21 Dolutegravir and rilpivirine J05AR22 Emtricitabine, tenofovir...
6 KB (538 words) - 04:59, 18 December 2023
2018 (Symfi) Mylan Yes Biktarvy emtricitabine tenofovir alafenamide bictegravir February 7, 2018 Gilead Sciences Yes Cimduo, Temixys lamivudine tenofovir...
6 KB (111 words) - 16:33, 9 February 2024
PMID 32130806. Orkin C, et al. (June 2020). "Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing...
19 KB (1,735 words) - 14:36, 21 August 2024
Integrase inhibitors (Integrase strand transfer inhibitors (INSTI)) Bictegravir (BIC) Cabotegravir (CAB) Dolutegravir (DTG)# Elvitegravir (EVG) Raltegravir...
3 KB (338 words) - 13:45, 27 July 2023
Inhibitors (NRTI) plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically- Suppressed...
16 KB (2,107 words) - 07:58, 7 January 2024
causing less side effects. Raltegravir, Elvitegravir, Dolutegravir, and Bictegravir are the only HIV-1 integrase inhibitor being used to treat HIV infections...
32 KB (4,154 words) - 08:34, 29 November 2023